Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2.
Xu C, Ren G, Cao G, Chen Q, Shou P, Zheng C, Du L, Han X, Jiang M, Yang Q, Lin L, Wang G, Yu P, Zhang X, Cao W, Brewer G, Wang Y, Shi Y.
J Biol Chem. 2013 Apr 19;288(16):11074-9. doi: 10.1074/jbc.M112.414862. Epub 2013 Feb 28.
Similar articles
IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells.
Imaizumi T, Tanaka H, Tajima A, Yokono Y, Matsumiya T, Yoshida H, Tsuruga K, Aizawa-Yashiro T, Hayakari R, Inoue I, Ito E, Satoh K.
Am J Nephrol. 2010;32(5):462-8. doi: 10.1159/000321365. Epub 2010 Oct 18.
SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production.
Zhang L, Dang RJ, Li H, Li P, Yang YM, Guo XM, Wang XY, Fang NZ, Mao N, Wen N, Jiang XX.
PLoS One. 2014 May 14;9(5):e97256. doi: 10.1371/journal.pone.0097256. eCollection 2014.
The ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p.
Lien GS, Liu JF, Chien MH, Hsu WT, Chang TH, Ku CC, Ji AT, Tan P, Hsieh TL, Lee LM, Ho JH.
Stem Cell Res Ther. 2014 Aug 13;5(4):97. doi: 10.1186/scrt486.
TGF-β promotes immune responses in the presence of mesenchymal stem cells.
Xu C, Yu P, Han X, Du L, Gan J, Wang Y, Shi Y.
J Immunol. 2014 Jan 1;192(1):103-9. doi: 10.4049/jimmunol.1302164. Epub 2013 Nov 29.
MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells.
Liu L, Wang Y, Fan H, Zhao X, Liu D, Hu Y, Kidd AR 3rd, Bao J, Hou Y.
Stem Cells. 2012 Aug;30(8):1756-70. doi: 10.1002/stem.1156.
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.
Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y.
Cell Stem Cell. 2008 Feb 7;2(2):141-50. doi: 10.1016/j.stem.2007.11.014.
Increased miR-155-5p expression in dermal mesenchymal stem cells of psoriatic patients: comparing the microRNA expression profile by microarray.
Hou RX, Liu RF, Zhao XC, Jia YR, An P, Hao ZP, Li JQ, Li XH, Yin GH, Zhang KM.
Genet Mol Res. 2016 Sep 2;15(3). doi: 10.4238/gmr.15038631.
Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells.
Han Z, Tian Z, Lv G, Zhang L, Jiang G, Sun K, Wang C, Bu X, Li R, Shi Y, Wu M, Wei L.
J Cell Mol Med. 2011 Nov;15(11):2343-52. doi: 10.1111/j.1582-4934.2010.01215.x.
MiR-30a attenuates immunosuppressive functions of IL-1β-elicited mesenchymal stem cells via targeting TAB3.
Hu E, Ding L, Miao H, Liu F, Liu D, Dou H, Hou Y.
FEBS Lett. 2015 Dec 21;589(24 Pt B):3899-907. doi: 10.1016/j.febslet.2015.11.001. Epub 2015 Nov 7.
C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells.
Xu G, Zhang Y, Zhang L, Roberts AI, Shi Y.
Stem Cells. 2009 Apr;27(4):942-8. doi: 10.1002/stem.22.
Interleukin-17 enhances immunosuppression by mesenchymal stem cells.
Han X, Yang Q, Lin L, Xu C, Zheng C, Chen X, Han Y, Li M, Cao W, Cao K, Chen Q, Xu G, Zhang Y, Zhang J, Schneider RJ, Qian Y, Wang Y, Brewer G, Shi Y.
Cell Death Differ. 2014 Nov;21(11):1758-68. doi: 10.1038/cdd.2014.85. Epub 2014 Jul 18.
The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143.
Zhao X, Liu D, Gong W, Zhao G, Liu L, Yang L, Hou Y.
Stem Cells. 2014 Feb;32(2):521-33. doi: 10.1002/stem.1543.
Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression.
Huang H, He J, Teng X, Yu Y, Ye W, Hu Y, Shen Z.
J Surg Res. 2013 Dec;185(2):896-903. doi: 10.1016/j.jss.2013.06.015. Epub 2013 Jun 29.
Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.
Chen Y, Boettger MK, Reif A, Schmitt A, Uçeyler N, Sommer C.
Mol Pain. 2010 Mar 2;6:13. doi: 10.1186/1744-8069-6-13.
Mesenchymal stem cells: a double-edged sword in regulating immune responses.
Li W, Ren G, Huang Y, Su J, Han Y, Li J, Chen X, Cao K, Chen Q, Shou P, Zhang L, Yuan ZR, Roberts AI, Shi S, Le AD, Shi Y.
Cell Death Differ. 2012 Sep;19(9):1505-13. doi: 10.1038/cdd.2012.26. Epub 2012 Mar 16.
Inducible nitric oxide synthase contributes to immune dysfunction following trauma.
Darwiche SS, Pfeifer R, Menzel C, Ruan X, Hoffman M, Cai C, Chanthaphavong RS, Loughran P, Pitt BR, Hoffman R, Pape HC, Billiar TR.
Shock. 2012 Nov;38(5):499-507. doi: 10.1097/SHK.0b013e31826c5afe.
Gene expression profile reveals that STAT2 is involved in the immunosuppressive function of human bone marrow-derived mesenchymal stem cells.
Yi T, Lee DS, Jeon MS, Kwon SW, Song SU.
Gene. 2012 Apr 15;497(2):131-9.
Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI, Eizirik DL.
Diabetologia. 1998 Sep;41(9):1101-8.
Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis.
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, Tang L, Ding Y, Jin Y.
J Bone Miner Res. 2013 Mar;28(3):559-73. doi: 10.1002/jbmr.1798.
Filters: Manage Filters